MINNEAPOLIS–(BUSINESS WIRE)–ASMS 2022 – Thermo Fisher Scientific Inc., the global leader in serving science, has launched new software for biopharmaceutical, proteomics and small molecule scientists to enable more comprehensive analysis of their data. The latest software updates bring new features that allow researchers to extract more insights from their new and existing data, streamline data interpretation, and standardize reporting with increased ease of use.
“It is essential that we continue to develop our software platforms to meet the growing data analysis needs of our customers, expanding analytical capabilities and providing better biological insights,” said August Specht, vice president , global research and development, chromatography and mass spectrometry, Thermo Scientific Fisher. “With the latest upgrades to our software suites, we can give scientists access to the latest technologies and purpose-built platforms to quickly and confidently turn data into meaningful results.”
Thermo Fisher Scientific introduces these latest software releases during the 70se American Society for Mass Spectrometry (ASMS) Conference on Mass Spectrometry and Related Topics, to be held June 5-9, 2022 at Booth 400 at the Minneapolis Convention Center, Minneapolis, Minnesota and the Hilton Minneapolis Grand Ballrooms E, F, G.
A complete solution for safe and simplified biotherapeutic characterization
Most recent Thermo Scientific BioPharma Finder 5.1 Software offers a complete solution for oligonucleotide analysis and biotherapeutic characterization workflows, providing increased confidence in results by comprehensively characterizing mass spectrometry data using advanced algorithms. Oligonucleotide-based biotherapies present unique challenges for characterization due to their complexity. The new software provides an enhanced suite of tools specifically designed to overcome these challenges and meet the needs of this rapidly growing field, quickly and confidently transforming complex data into meaningful results. Improvements to the kinetic prediction model for oligonucleotides allow for more confident prediction and matching. Enhanced data review tools and tables provide simplified review and results reporting of complex oligonucleotide datasets.
Redefining Proteomics Research Capabilities Leveraging Artificial Intelligence
Proteomics scientists can now benefit from the latest Thermo Scientific Proteome Discoverer 3.0 Software in combination with MSAID’s CHIMERYS intelligent search algorithm, leveraging artificial intelligence to more fully interpret data generated by Thermo Scientific Orbitrap mass spectrometers. This innovative approach dramatically increases the number of unique peptide identifications, improves protein coverage and quantification capabilities, and enables scientists to discover more from their data. The new intelligent search algorithm also facilitates high-throughput analysis and dependent acquisition of wide isolation window data for synergistic performance improvements. This deeper exploration of data expands the means by which proteomics scientists can acquire and apply their data.
Improve untargeted small molecule workflows with new peak detection and quality algorithms
Small molecule researchers can now take advantage of a faster and more sensitive peak detection algorithm with the latest Thermo Scientific Compound Discoverer 3.3 Software to detect more compounds in less time. Filtering large datasets down to relevant compounds is now easier than ever using the new Maximum Quality feature to streamline data processing and review. Improve confidence in compound annotations with MSn spectral tree search capabilities in tandem with the Thermo Scientific mzCloud spectral library to deal with the most difficult unknown compounds. Compound Discoverer 3.3 software, which has been optimized to handle large data sets and detect low abundance compounds, will help scientists in metabolomic, pharmaceutical, environmental, food safety, clinical and forensic applications acquire the results they need. they need to advance science.
For more information on Thermo Fisher Scientific solutions on display at ASMS 2022, please visit www.thermofisher.com/ASMS.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with annual sales of approximately $40 billion. Our mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life science research, solving complex analytical challenges, increasing their laboratory productivity, improving patient health through diagnostics, or developing and manufacturing life-changing therapies, we are there to support them. Our global team delivers an unparalleled combination of innovative technology, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.